Need help? Our team of experienced experts is here for you with full support.
AKA-276
4-Hydroxycinnamic Acid
Cat. No.
AKA-276
CAS No.
501-98-4
MF
C9H8O3
MW
164.158
p-Coumaric acid (trans-4-Hydroxycinnamic acid) is an isomer of cinnamic acid.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
4-Hydroxycinnamic Acid
CAS No.
501-98-4
MF
C9H8O3
MW
164.158
Specification
98%
Research Area
Intermediate
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
p-Coumaric acid (trans-4-Hydroxycinnamic acid) is an isomer of cinnamic acid. Packing: 1kg/bag; 25kg/drum or as request Availability: In Stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Hu X, et al. The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells. Frontiers in Oncology. 2020 Oct 16;10:558414.
[2]. Lou Z, et al. p-Coumaric acid kills bacteria through dual damage mechanisms. Food Control. 2012;25(2):550-554.
[3]. Sharma SH, et al. Protective effect of p-coumaric acid against 1,2 dimethylhydrazine induced colonic preneoplastic lesions in experimental rats. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie. 2017 Oct;94:577-588.
[4]. Rafiee Z, et al. p-Coumaric acid mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis. Archives of Medical Research. 2020 Jan;51(1):32-40.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.